SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

FSD Pharma Inc. – ‘6-K’ for 12/5/23

On:  Tuesday, 12/5/23, at 10:33am ET   ·   For:  12/5/23   ·   Accession #:  1654954-23-15160   ·   File #:  1-39152

Previous ‘6-K’:  ‘6-K’ on 11/30/23 for 11/29/23   ·   Next:  ‘6-K’ on 12/15/23 for 12/14/23   ·   Latest:  ‘6-K’ on 5/7/24 for 5/6/24   ·   1 Reference:  By:  FSD Pharma Inc. – ‘424B5’ on 2/20/24

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

12/05/23  FSD Pharma Inc.                   6-K        12/05/23    2:42K                                    Blueprint/FA

Current, Quarterly or Annual Report by a Foreign Issuer   —   Form 6-K   —   SEA’34

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 6-K         Current, Quarterly or Annual Report by a Foreign    HTML     10K 
                Issuer                                                           
 2: EX-99.1     Press Release                                       HTML     22K 


‘6-K’   —   Current, Quarterly or Annual Report by a Foreign Issuer


This is an HTML Document rendered as filed.  [ Alternative Formats ]



 C: 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of: December 2023

 

Commission File Number: 001-39152

 

FSD PHARMA INC.

(Translation of registrant's name into English)

 

199 Bay St., Suite 4000

Toronto, Ontario M5L 1A9, Canada

(Address of principal executive office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F ☒     Form 40-F ☐

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

FSD Pharma Inc.

(Registrant)

 

 

Date: December 5, 2023

By:

/s/ Nathan Coyle

 

Nathan Coyle, Chief Financial Officer

 

 

 
2

 

 

EXHIBIT INDEX

 

Exhibit

 

Description

 

 

 

99.1

 

Press Release – December 5, 2023 - FSD Pharma Inc. Announces Closing of Private Placement

 

 
3

 


Dates Referenced Herein

This ‘6-K’ Filing    Date    Other Filings
Filed on / For Period end:12/5/23None on these Dates
 List all Filings 


1 Subsequent Filing that References this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/20/24  FSD Pharma Inc.                   424B5       2/16/24    1:863K                                   RDG Filings/FA
Top
Filing Submission 0001654954-23-015160   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Mon., May 13, 9:42:22.1pm ET